ADALUZIS

Serial Number 90849710
734

Registration Progress

Application Filed
Jul 27, 2021
Under Examination
Jan 3, 2023
Approved for Publication
Nov 8, 2022
Published for Opposition
Nov 8, 2022
Registered

Attorney Assistance

Statement of Use Due - Extension 5 Granted
Due: Jul 03, 2028 888 days
Statement of Use required (all extensions used)

Trademark Image

ADALUZIS

Basic Information

Serial Number
90849710
Filing Date
July 27, 2021
Published for Opposition
November 8, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Dec 10, 2025
Application
Pending
Classes
005

Rights Holder

Basilea Pharmaceutica AG

99
Address
Grenzacherstrasse 487
Basel 4058
CH

Ownership History

Basilea Pharmaceutica AG

Original Applicant
99
Basel CH

Basilea Pharmaceutica AG

Owner at Publication
99
Basel CH

Legal Representation

Attorney
Evan A. Raynes

USPTO Deadlines

Next Deadline
888 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
July 03, 2028

Application History

35 events
Date Code Type Description Documents
Dec 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 10, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 24, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 10, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 24, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 16, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 2, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 2, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 2, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 19, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 19, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 27, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 27, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 27, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 3, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 8, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 19, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 4, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 3, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 3, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 3, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 22, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 22, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 22, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 24, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 30, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases

Classification

International Classes
005